Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The Company is engaged in development and then building of the Linac Image Guided Hadron Technology (LIGHT) proton beam cancer therapy device and management of healthcare related property. The Company's segments include Development of Proton Therapy-UK; Development of Proton Therapy-Switzerland; Development of Proton Therapy-USA, and Healthcare-related properties-UK. Its LIGHT system uses accelerators, which is a series of modular units. This feature offers hospitals and centers to customize treatment plans based on a range of energies. The Company's Research and development/ADAM S.A. (R&D/ADAM) facility is located on the campus of European Council for Nuclear Research (CERN), Geneva, Switzerland, and a manufacturing plant, clinical research and clinician training facility in Syracuse, the United States.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:AVO
- CUSIP: N/A
- Web: N/A
Capitalization:- Market Cap: £12.76 million
- Outstanding Shares: 56,733,000
Average Prices:- 50 Day Moving Avg: GBX 26.50
- 200 Day Moving Avg: GBX 53.69
- 52 Week Range: GBX 20.18 - GBX 209.88
P/E:- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
Sales & Book Value:- Annual Revenue: N/A
- Price / Sales: N/A
- Book Value: GBX 0.48 per share
- Price / Book: 0.47
Profitability:Misc:- Average Volume: 347,438 shs.
Frequently Asked Questions for Advanced Oncotherapy PLC (LON:AVO)
What is Advanced Oncotherapy PLC's stock symbol?
Advanced Oncotherapy PLC trades on the London Stock Exchange (LON) under the ticker symbol "AVO."
Who are some of Advanced Oncotherapy PLC's key competitors?
Some companies that are related to Advanced Oncotherapy PLC include Ubisense Group PLC (UBI), Universe Group plc (UNG), Hardide Plc (HDD), Gulfsands Petroleum plc (GPX), Premaitha Health PLC (NIPT), Sacoil Holdings Limited (SAC), Cambridge Cognition Holdings PLC (COG), San Leon Energy Plc (SLE), Global Invacom Group Ltd (GINV), Versarien PLC (VRS), Sirius Petroleum Plc (SRSP), Dekeloil Public Ltd (DKL), Egdon Resources Plc (EDR), Redstoneconnect PLC (REDS), UK Oil & Gas Investments PLC (UKOG), Spectra Systems Corp (SPSY), ECO (ATLANTIC) OIL & GAS LTD COM (ECO) and Artilium plc (ARTA).
How do I buy Advanced Oncotherapy PLC stock?
Shares of Advanced Oncotherapy PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Advanced Oncotherapy PLC stock cost?
One share of Advanced Oncotherapy PLC stock can currently be purchased for approximately GBX 22.50.
Consensus Ratings for Advanced Oncotherapy PLC (LON:AVO) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | 1 Hold Rating |
| Consensus Rating: | Hold (Score: 2.00) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Advanced Oncotherapy PLC (LON:AVO)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 2/27/2017 | Beaufort Securities | Downgrade | Hold | |  |
| 6/3/2015 | Westhouse Securities | Reiterated Rating | Under Review | | |
(Data available from 5/24/2015 forward)
Earnings History for Advanced Oncotherapy PLC (LON:AVO)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Advanced Oncotherapy PLC (LON:AVO)Current Year EPS Consensus Estimate: $-6.71 EPS
Dividend History for Advanced Oncotherapy PLC (LON:AVO)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Advanced Oncotherapy PLC (LON:AVO)Insider Trades by Quarter for Advanced Oncotherapy PLC (LON:AVO)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 5/15/2017 | Steve Myers OBE | Insider | Buy | 400,000 | GBX 26 | £104,000 | |
| 5/9/2017 | Christopher Nutting | Insider | Buy | 202,500 | GBX 25 | £50,625 | |
| 4/25/2017 | Michael J Sinclair | Insider | Buy | 200,000 | GBX 30 | £60,000 | |
| 4/24/2017 | Enrico Cipro Vanni | Insider | Buy | 100,000 | GBX 27 | £27,000 | |
| 4/12/2017 | Enrico Cipro Vanni | Insider | Buy | 100,000 | GBX 28 | £28,000 | |
| 4/4/2017 | Enrico Cipro Vanni | Insider | Buy | 25,000 | GBX 29 | £7,250 | |
| 4/3/2017 | Michael J Sinclair | Insider | Buy | 100,000 | GBX 28 | £28,000 | |
| 1/3/2017 | Enrico Cipro Vanni | Insider | Buy | 25,000 | GBX 87 | £21,750 | |
| 12/29/2016 | Enrico Cipro Vanni | Insider | Buy | 25,000 | GBX 66 | £16,500 | |
| 12/22/2016 | Enrico Cipro Vanni | Insider | Buy | 25,000 | GBX 60 | £15,000 | |
| 12/20/2016 | Enrico Cipro Vanni | Insider | Buy | 25,000 | GBX 55 | £13,750 | |
| 12/19/2016 | Enrico Cipro Vanni | Insider | Buy | 25,000 | GBX 50 | £12,500 | |
| 7/11/2016 | Bradfield ,Michael | Insider | Buy | 30,000 | GBX 135 | £40,500 | |
| 7/8/2016 | Bradfield ,Michael | Insider | Buy | 10,000 | GBX 120 | £12,000 | |
| 7/7/2016 | Bradfield ,Michael | Insider | Buy | 10,000 | GBX 112 | £11,200 | |
| 7/6/2016 | Bradfield ,Michael | Insider | Buy | 50,000 | GBX 102 | £51,000 | |
| 12/18/2015 | Bradfield ,Michael | Insider | Buy | 750,000 | GBX 7 | £52,500 | |
| 12/17/2015 | Bradfield ,Michael | Insider | Buy | 1,000,000 | GBX 6 | £60,000 | |
| 12/16/2015 | Bradfield ,Michael | Insider | Buy | 750,000 | GBX 6 | £45,000 | |
| 7/20/2015 | Vanni ,Enrico Cipro | Insider | Buy | 1,000,000 | GBX 8 | £80,000 | |
| 7/1/2015 | Sinclair,Michael J | Insider | Sell | 7,000,000 | GBX 0.08 | £5,600 | |
| 6/5/2015 | Michael Bradfield | Insider | Buy | 1,500,000 | GBX 9.81 | £147,150 | |
| 2/4/2015 | Michael Bradfield | Insider | Buy | 500,000 | GBX 4.10 | £20,500 | |
(Data available from 1/1/2013 forward)
Headline Trends for Advanced Oncotherapy PLC (LON:AVO)
Latest Headlines for Advanced Oncotherapy PLC (LON:AVO)
| Source: |
|
Advanced Oncotherapy PLC (AVO) Chart for Wednesday, May, 24, 2017
